Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Regulatory Approval

Srinibas Pradhan Constructions Regulatory Approval

Srinibas Pradhan Constructions Ltd. has received 'A Class' P.W.D. Contractors Registration from the Works Department, Odisha. This license, valid until March 31, 2028, enables the company to participate in government infrastructure tenders, enhancing its eligibility for future business growth.

Key figures
Execution periodValid up to 31st March, 2028
Source

NSE filing, NSE: SPCON. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Srinibas Pradhan Constructions Ltd: key numbers

Share price
₹207.50
Market cap
₹163.1 Cr
Revenue (annual)
₹90.21 Cr
Net profit (annual)
₹8.21 Cr
P/E (TTM)
19.9×Sector 32.2×
Promoter holding
62.10%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Srinibas Pradhan Constructions Ltd

All →

Other regulatory approval announcements

All →
21:58 IST BSE
Regulatory ApprovalNesco Ltd NESCO

Nesco Regulatory Approval

Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.

19:10 IST NSE
Regulatory ApprovalGrasim Industries Ltd GRASIM

Grasim Industries Regulatory Approval

CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.

08:07 IST BSE
Regulatory ApprovalHikal Ltd HIKAL

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

08:05 IST BSE
Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMA

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.

20:00 IST NSE
Regulatory ApprovalRNFI Services Ltd RNFI

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.